| Ytd | -49.09% | |
| 1y | -65.00% |
| Open | 2.81 | Prev Close | 2.87 | Low | 2.68 | High | 2.81 | Mkt Cap | 6.13M |
| Vol | 43.78K | Avg Vol | 479.35K | EPS | N/A | P/E | N/A | Forward P/E | -0.79 |
| Beta | 1.43 | Short Ratio | 0.65 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.19 | 200-d Avg | 4.69 | 1yr Est | 7.50 |
LUCID CAPITAL MARKETS analyst Elemer Piros initiates coverage on Adial Pharmaceuticals (NASDAQ:AD
About the TransactionsThe acquisition of Azora was structured as an asset acquisition pursuant to wh
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(1.48) per share which beat the an
Adial Pharmaceuticals completes AD04 demo batch, validating process transfer and enabling Phase 3 pr
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarter
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34%
During Monday's session, 201 stocks hit new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ
Gainers